Modulim
Modulim is dedicated to preventing the complications of chronic wounds due to diabetes, peripheral arterial disease, and burns. Mapping tissue health at the point-of-care is key to preventing non-healing chronic wounds. This is made possible only by Modulim's handheld microvascular imaging solution, powered by Spatial Frequency Domain Imaging (SFDI), that empowers healthcare teams with proprietary data and proactive, personalized AI insights.
Modulim
2755 Bristol Street. Suite 285 Costa Mesa, CA 92626
Modulim is currently seeking investment
Modulim is seeking a series-a investment in the range of 5m-20m
What We Do
The first non-contact, noninvasive microvascular assessment tool that uses spatial frequency domain imaging (SFDI) to measure tissue oxygenation and perfusion at the point-of-care in seconds.
A Limb Assessment, Management, & Preservation solution that integrates into existing workflows, allowing for efficient patient assessment and management.
A HIPAA compliant cloud infrastructure for secure storage and sharing of patient data, enabling better care coordination.
Spatial frequency domain imaging (SFDI) technology that provides noninvasive, quantitative measurements of tissue oxygen availability, extraction, and saturation.
Application Area
Show More (2)Battlefield Resuscitation
FDA Regulated Medical Devices
Digital Health Technologies
Show LessKey People
News & Updates
Modulim received a three-year renewal of their ISO:13485 certification after a comprehensive review of the company’s quality system.
Modulim announced the grant of United States Patent US11751769B2 for systems and methods to assess diabetic circulatory complications.
A new clinical case study was published assessing the impact of revascularization on microvascular oxygenation and perfusion using SFDI.
Patent granted for a system and method to assess diabetic circulatory complications.